Although osteoporosis is seen in the elderly, and elderly people are a vulnerable group in getting COVID-19 infection, there is NO definite evidence that osteoporosis increases the risk of being infected with COVID-19. Osteoporosis involves the abnormal metabolic processes affecting bone strength and is not linked to the immune system that is embattled during the infection.
Osteoporosis itself does not increase the risk of developing serious complications from COVID-19, neither the disease itself and the medications used will alter the metabolic course or affect the efficacy of the current treatment for the disease.
Similar to the general measures given by the WHO to prevent transmission of COVID-19, to protect yourself and others from infection, everyone must practice the following:
Clear policies, training, and education for staff in the work place to increase awareness of COVID-19 are essential. Anyone who is unwell or who develop symptoms should stay at home, self-isolate and contact a medical professional or the local COVID-19 information line for advice on testing and referral.
It is generally recommended for people to be vaccinated against COVID-19, especially those belonging to the older population (who might have osteoporosis). The medications should not be interrupted for vaccination purposes solely, however, patients are encouraged to visit their physicians for advice on the timing of the administration of the vaccine.